Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: Results from a large, consecutive norwegian series

Annals of Oncology

Volumn 24, Issue 5, 2013, Pages 1274-1282

  Merok, M A ^a,b,c   Ahlquist, T ^b,c   Royrvik E C ^b,c   Tufteland, K F ^d   Hektoen, M ^b,c   Sjo, O H ^a   Mala, T ^a   Svindland, A ^d   Lothe, R A ^b,c   Nesbakken, A ^a,c  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adenocarcinoma; Colorectal neoplasms; Lymph nodes; Microsatellite instability; Prevalence; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; COLON CANCER; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; NORWAY; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RECTUM CANCER; RECURRENCE FREE SURVIVAL;

EID: 84877126189     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds614     Document Type: Article

References (48)

1. Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 2009; 18: 1688-1694.
3. Larsen IK. Cancer in Norway 2009. Cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway 2011.
4. Compton CC, Fielding LP, Burgart LJ et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124: 979-994.
5. Chapuis PH, Dent OF, Fisher R et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985; 72: 698-702.
6. Newland RC, Dent OF, Lyttle MN et al. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer 1994; 73: 2076-2082.
7. Jestin P, Nilsson J, Heurgren M et al. Emergency surgery for colonic cancer in a defined population. Br J Surg 2005; 92: 94-100.
8. Chang GJ, Rodriguez-Bigas MA, Skibber JM et al. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 2007; 99: 433-441.
9. Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 2002; 26: 179-189.
10. Sarli L, Bader G, Iusco D et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer 2005; 41: 272-279.
11. Swanson RS, Compton CC, Stewart AK et al. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003; 10: 65-71.
12. Sjo OH, Lunde OC, Nygaard K et al. Tumour location is a prognostic factor for survival in colonic cancer patients. Colorectal Dis 2008; 10: 33-40.
13. Deschoolmeester V, Baay M, Specenier P et al. A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy. Oncologist 2010; 15: 699-731.
14. Lothe RA, Peltomaki P, Meling GI et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993; 53: 5849-5852.
15. Aaltonen LA, Peltomaki P, Leach FS et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260: 812-816.
16. Ionov Y, Peinado MA, Malkhosyan S et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363: 558-561.
17. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260: 816-819.
18. Marra G, Boland CR. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 1995; 87: 1114-1125.
19. Bronner CE, Baker SM, Morrison PT et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994; 368: 258-261.
20. Leach FS, Nicolaides NC, Papadopoulos N et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993; 75: 1215-1225.
21. Cunningham JM, Christensen ER, Tester DJ et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 1998; 58: 3455-3460.
22. Kane MF, Loda M, Gaida GM et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997; 57: 808-811.
23. Wheeler JM, Bodmer WF, Mortensen NJ. DNA mismatch repair genes and colorectal cancer. [Review] [109 refs]. Gut 2000; 47: 148-153.
24. Benatti P, Gafa R, Barana D et al. Microsatellite instability and colorectal cancer prognosis. Clin Cancer Res 2005; 11: 8332-8340.
25. Malesci A, Laghi L, Bianchi P et al. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer. Clin Cancer Res 2007; 13: 3831-3839.
26. Ogino S, Nosho K, Kirkner GJ et al. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 2009; 58: 90-96.
27. Jass JR, Do KA, Simms LA et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut 1998; 42: 673-679.
28. Samowitz WS, Curtin K, Ma KN et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 2001; 10: 917-923.
29. Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005; 23: 609-618.
30. Guastadisegni C, Colafranceschi M, Ottini L et al. Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data. [Review]. Eur J Cancer 2010; 46: 2788-2798.
31. Boland CR, Thibodeau SN, Hamilton SR et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248-5257.
32. Punt CJ, Buyse M, Kohne CH et al. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst 2007; 99: 998-1003.
33. Lanza G, Gafa R, Santini A et al. Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients. J Clin Oncol 2006; 24: 2359-2367.
34. Gryfe R, Kim H, Hsieh ET et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000; 342: 69-77.
35. Halling KC, French AJ, McDonnell SK et al. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst 1999; 91: 1295-1303.
36. McShane LM, Altman DG, Sauerbrei W et al. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 2005; 97: 1180-1184.
37. Des Guetz G, Schischmanoff O, Nicolas P et al. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis. [Review] [36 refs]. Eur J Cancer 2009; 45: 1890-1896.
38. Agesen TH, Sveen A, Merok MA et al. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Gut 2012; 61: 1560-1567.
39. Diep CB, Thorstensen L, Meling GI et al. Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients. J Clin Oncol 2003; 21: 820-829.
40. Jernvall P, Makinen MJ, Karttunen TJ et al. Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers. Eur J Cancer 1999; 35: 197-201.
41. Salahshor S, Kressner U, Fischer H et al. Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor. Br J Cancer 1999; 81: 190-193.
42. Ward RL, Cheong K, Ku SL et al. Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability. J Clin Oncol 2003; 21: 3729-3736.
43. Jass JR. Subsite distribution and incidence of colorectal cancer in New Zealand, 1974-1983. Dis Colon Rectum 1991; 34: 56-59.
44. Sinicrope FA, Rego RL, Halling KC et al. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology 2006; 131: 729-737.
45. Eveno C, Nemeth J, Soliman H et al. Association between a high number of isolated lymph nodes in T1 to T4 N0M0 colorectal cancer and the microsatellite instability phenotype. Arch Surg 2010; 145: 12-17.
46. Belt EJ, te Velde EA, Krijgsman O et al. High lymph node yield is related to microsatellite instability in colon cancer. Ann Surg Oncol 2012; 19: 1222-1230.
47. Soreide K, Nedrebo BS, Soreide JA et al. Lymph node harvest in colon cancer: influence of microsatellite instability and proximal tumor location. World J Surg 2009; 33: 2695-2703.
48. Sjo OH, Merok MA, Svindland A et al. Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer. Dis Colon Rectum 2012; 55: 307-315.